3
Jul 2026
Insilico Medicine highlights AI drug discovery progress at executive summit
Dr. Alex Aliper, Co-founder and President of Insilico Medicine, will attend the AI for Good Global Summit 2026 in Geneva, Switzerland, on July 7.
Stay Informed!
3
Jul 2026
Survey reveals gaps in acute kidney injury prevention across intensive care
Acute kidney injury (AKI) remains one of the most frequent and clinically significant complications among critically ill patients, affecting nearly half of those admitted to intensive care units (ICUs).
3
Jul 2026
New analysis reveals biological features of treatment-resistant aggressive lymphoma
Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized.
3
Jul 2026
Researchers uncover unexpected bacterial strategy for surviving antibiotic stress
Escherichia coli (E. coli) are mostly harmless bacteria that live in the intestines of animals and humans. They are the most well-studied bacteria and, often, when scientists discover something about E. coli, they extrapolate that discovery across all bacteria.
3
Jul 2026
Blood test may predict which colorectal cancer patients benefit from chemotherapy
A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.
3
Jul 2026
Feeder-free TIL expansion system makes advanced cancer immunotherapy safer
Conventional TIL therapy, clinically validatedrecently with the U.S. Food and Drug Administration approval of lifileucel for advanced melanoma,stillfaces substantial hurdles.
3
Jul 2026
New synthetic grafting material kills bone cancer and regenerates bone
Primary bone tumors, such as osteosarcoma, have seen stagnant survival rates over the past four decades. Surgical removal of the tumor is critical, but local recurrence may occur when tumours are close to vital structures, often resulting in amputation
3
Jul 2026
New breast cancer classification system predicts immunotherapy response success
The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.
3
Jul 2026
Study reveals how specific aging cells help repair injured tendons
Tendon injuries, though very common, frequently heal with scar tissue, which is less flexible and more prone to future injury.
3
Jul 2026
Researchers advance fertility options for childhood cancer survivors
Researchers at Karolinska Institutet have demonstrated that it is possible to create early germ cells from preserved testicular tissue of young boys facing cancer therapy.
